(Q41923524)

14 October 2017

Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies (English)

1 reference

14 October 2017

31

Pasi A Jänne

1 reference

14 October 2017

Doron Lipson

1

1 reference

14 October 2017

Marzia Capelletti

2

1 reference

14 October 2017

Roman Yelensky

3

1 reference

14 October 2017

Geoff Otto

4

1 reference

14 October 2017

Alex Parker

5

1 reference

14 October 2017

Mirna Jarosz

6

1 reference

14 October 2017

John A Curran

7

1 reference

14 October 2017

Sohail Balasubramanian

8

1 reference

14 October 2017

Troy Bloom

9

1 reference

14 October 2017

Kristina W Brennan

10

1 reference

14 October 2017

Amy Donahue

11

1 reference

14 October 2017

Sean R Downing

12

1 reference

14 October 2017

Garrett M Frampton

13

1 reference

14 October 2017

Lazaro Garcia

14

1 reference

14 October 2017

Frank Juhn

15

1 reference

14 October 2017

Kathy C Mitchell

16

1 reference

14 October 2017

Emily White

17

1 reference

14 October 2017

Jared White

18

1 reference

14 October 2017

Zac Zwirko

19

1 reference

14 October 2017

Tamar Peretz

20

1 reference

14 October 2017

Hovav Nechushtan

21

1 reference

14 October 2017

Lior Soussan-Gutman

22

1 reference

14 October 2017

Jhingook Kim

23

1 reference

14 October 2017

Hidefumi Sasaki

24

1 reference

14 October 2017

Hyeong Ryul Kim

25

1 reference

14 October 2017

Seung-il Park

26

1 reference

14 October 2017

Dalia Ercan

27

1 reference

14 October 2017

Christine E Sheehan

28

1 reference

14 October 2017

Jeffrey S Ross

29

1 reference

14 October 2017

Maureen T Cronin

30

1 reference

14 October 2017

Philip J Stephens

32

1 reference

14 October 2017

language of work or name

English

0 references

publication date

12 February 2012

1 reference

14 October 2017

1 reference

14 October 2017

18

1 reference

14 October 2017

382-384

1 reference

14 October 2017

3

1 reference

https://scigraph.springernature.com/pub.10.1038/nm.2673

14 October 2017

0 references

cites work

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3916180

Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3916180

Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3916180

COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3916180

Deregulation of the PI3K and KRAS signaling pathways in human cancer cells determines their response to everolimus

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3916180

The activating mutation R201C in GNAS promotes intestinal tumourigenesis in Apc(Min/+) mice through activation of Wnt and ERK1/2 MAPK pathways

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3916180

PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3916180

Cotreatment with panobinostat and JAK2 inhibitor TG101209 attenuates JAK2V617F levels and signaling and exerts synergistic cytotoxic effects against human myeloproliferative neoplastic cells.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3916180

Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3916180

Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3916180

Sorafenib potently inhibits papillary thyroid carcinomas harboring RET/PTC1 rearrangement

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3916180

Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3916180

KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3916180

Targeting the DNA repair defect of BRCA tumours

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3916180

Discovery of a potent and selective inhibitor of cyclin-dependent kinase 4/6.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3916180

KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3916180

EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3916180

In vivo activation of the p53 pathway by small-molecule antagonists of MDM2

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3916180

A new oncogene in human thyroid papillary carcinomas and their lymph-nodal metastases

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3916180

A novel KIF5B-ALK variant in nonsmall cell lung cancer.

5 June 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FNM.2673

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/NM.2673

1 reference

14 October 2017

1 reference

14 October 2017

1 reference